335 results on '"Elkord, Eyad"'
Search Results
2. PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients
3. Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study
4. Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers
5. Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients
6. Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer
7. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
8. Role of circular RNAs in colorectal tumor microenvironment
9. Differential gene expression of tumor-infiltrating CD33+ myeloid cells in advanced- versus early-stage colorectal cancer
10. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
11. Designing a broad-spectrum integrative approach for cancer prevention and treatment
12. Integrated whole transcriptome and small RNA analysis revealed multiple regulatory networks in colorectal cancer
13. Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
14. Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
15. Correction to: Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer
16. Editorial: Novel biomarkers in tumor immunity and immunotherapy.
17. Immune checkpoint inhibitors: recent progress and potential biomarkers
18. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer
19. Correction to: Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
20. Structure-based small inhibitors search combined with molecular dynamics driven energies for human programmed cell death-1 (PD-1) protein
21. Long non-coding RNA (lncRNA) transcriptional landscape in breast cancer identifies LINC01614 as non-favorable prognostic biomarker regulated by TGFβ and focal adhesion kinase (FAK) signaling
22. PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients
23. Editorial: Mediterranean diet and cancer: Experimental and epidemiological perspectives
24. Myeloid cells in circulation and tumor microenvironment of breast cancer patients
25. Correlations between Circulating and Tumor-Infiltrating CD4+ Treg Subsets with Immune Checkpoints in Colorectal Cancer Patients with Early and Advanced Stages
26. Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
27. Promising use of immune cell‐derived exosomes in the treatment of SARS‐CoV‐2 infections
28. DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
29. DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
30. Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients
31. Associations of Complete Blood Count Parameters with Disease-Free Survival in Right- and Left-Sided Colorectal Cancer Patients
32. Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19
33. T‐cell responses and therapies against SARS‐CoV‐2 infection
34. Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
35. Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
36. Correlations between Circulating and Tumor-Infiltrating CD4+ T Cell Subsets with Immune Checkpoints in Colorectal Cancer
37. DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR– myeloid cells, compared with HLA-DR+ antigen-presenting cells
38. Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population
39. Salmonella-mediated tumor regression involves targeting of tumor myeloid suppressor cells causing a shift to M1-like phenotype and reduction in suppressive capacity
40. Neuropilin 1: function and therapeutic potential in cancer
41. SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity
42. Editorial: CD4+ T Cells in Cancer Immunotherapies
43. Correlations between Circulating and Tumor-Infiltrating CD4 + Treg Subsets with Immune Checkpoints in Colorectal Cancer Patients with Early and Advanced Stages.
44. Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8 + Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients.
45. Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4+ T Cells Associated with Poor Disease-Specific Survival
46. Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)
47. CD4+ T-cell recognition of human 5T4 oncofoetal antigen: implications for initial depletion of CD25+ T cells
48. Adoptive transfer of Treg depleted autologous T cells in advanced renal cell carcinoma
49. Associations of different immune checkpoints-expressing CD4+ Treg/ T cell subsets with disease-free survival in colorectal cancer patients.
50. Correlations between Circulating and Tumor-Infiltrating CD4 + T Cell Subsets with Immune Checkpoints in Colorectal Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.